Full-Day Session at Age Management Medicine Group Conference in November

Evidence-based, continuing medical education in Age Management Medicine

Women’s health and hormone treatment plans are at the center of our changing medical landscape. New evidence-based approaches, research findings, and emerging sciences are being introduced at every turn. Physicians need to stay informed and well versed or they’ll fall behind.

Men’s hormone therapy, from testosterone use to cardiovascular and sexual health, may get major press, but that is about to change. The Age Management Medical Group (AMMG)—presenter of the CME-accredited “23rd Clinical Applications in Age Management Medicine Conference”—is balancing the equation with a full-day focus on Women’s Health and Hormones, which includes its cornerstone lecture, “Consensus Panel Guidelines for the Use of Testosterone in Women.”

Spearheaded by Dr. Gary Donovitz, a 20-year innovator of bioidentical hormone therapy, the Consensus Panel’s ten resolutions on testosterone use in women’s health reflect the unanimous approval of an expert consortium, representing a range of medical specialties, from obstetrics and gynecology to endocrinology, internal medicine, and urology. The endeavor is a kindred response to the work of Dr. Abraham Morgentaler—a recognized authority on men’s health—and the nine resolutions of his international expert panel that confronted the controversies and misinformation of testosterone use in men.

“Women’s health and hormone treatment plans are at the center of our changing medical landscape. New evidence-based approaches, research findings, and emerging sciences are being introduced at every turn. Physicians need to stay informed and well versed or they’ll fall behind,” said Greg Fillmore, AMMG Conference…

Read the full article at the Original Source..

Back to Top